Shows
Gesundheitspolitik im Fokus«EFAS: Wie setzen Kassen und Kantone den Gamechanger im Schweizer Gesundheitssystem um?»mit Regierungsrätin Michaela Tschuor, Gesundheits- und Sozialdirektorin des Kantons Luzern und Philomena Colatrella, CEO der CSS.
Die einheitliche Finanzierung von stationären und ambulanten Leistungen verspricht ein Gamechanger zu sein. EFAS eliminiert Fehlanreize in den bestehenden Versorgungsstrukturen und bringt die ambulante Versorgung mit Tempo voran. Die Umsetzung ist allerdings ein grösserer Akt, den die Kassen und die Kantone rasch und miteinander zu gestalten haben. Wie setzen Kassen und Kantone die grosse Reform konkret um? Wo stehen sie im Prozess und was steht über EFAS hinaus an, um das Schweizer Gesundheitssystem heute für die Zukunft fit zu mache...2025-05-0543 min
Gesundheitspolitik im Fokus«Zugang zu innovativen Therapien: Solidarität als Schlüssel»mit Urs Bieri, Co-Leiter und Mitglied des Verwaltungsrates gfs.bern
Im Gegensatz zu klassischen Therapien setzen innovative Therapien auf Heilung und Regeneration. In der Regel sind sie hochwirksam, aber auch ressourcenintensiv. Das stellt die Akteure im Gesundheitswesen vor neue Herausforderungen. Hersteller, Leistungserbringer und Behörden arbeiten daran, Lösungen für die drängenden Fragen zu finden, die letztlich den Zugang ermöglichen. Doch wo steht die Bevölkerung in dieser Frage? Urs Bieri Co-Leiter und Mitglied des Verwaltungsrates des renommierten Meinungsforschungsinstituts gfs.bern hat Bürgerinnen und Bürger dazu befragt. Dabei wird klar: Alle sollen den gleichen Zugang z...2025-04-0730 min
Gesundheitspolitik im Fokus«Ein Nationaler Krebsplan für die Schweiz: Der Handlungsbedarf ist dringend»mit den Ständeräten Erich Ettlin und Damian Müller
Der aktuelle Podcast beleuchtet die Dringlichkeit eines Nationalen Krebsplans für die Schweiz. Die Ständeräte Erich Ettlin (Die Mitte) und Damian Müller (FDP.Die Liberalen) diskutieren mit Heike Scholten die Hintergründe für den «Nationalen Krebsplan», die Herausforderungen bei dessen Umsetzung und die erwartete Verabschiedung durch den Bundesrat im Sommer 2026. Im Gespräch wird deutlich: Die Schweiz braucht mehr Koordination in der Krebsbekämpfung, von der Früherkennung und Prävention über innovative Therapien bis zur Nachsorge. Gerade weil das Gesundheitswesen in den Kantonen angesiedelt ist...2025-03-0541 min
Gesundheitspolitik im Fokus«Wie solidarisch ist das Gesundheitssystem Schweiz? Die Swiss Inequality Database Health schafft Klarheit.»mit Dr. oec. Melanie Häner-Müller, Leiterin des Bereichs Sozialpolitik und Bildungsverantwortliche des Instituts für Schweizer Wirtschaftspolitik IWP an der Universität Luzern
Spätestens, wenn die Gesundheitsministerin oder der Gesundheitsminister die Krankenkassenprämien kommuniziert, entfacht sich die Debatte um die Solidarität im Gesundheitswesen neu. Doch was genau bedeutet Solidarität im Gesundheitswesen, und wie lässt sie sich messen? Darüber und über die komplexe Umverteilungssituation – sowohl auf der Finanzierungs- als auch auf der Leistungsseite – sprechen wir mit Dr. Melanie Häner-Müller. Sie ist Ökonomin, leitet den Bereich Sozialpolitik am Institut für Schweizer Wirtschaftspolitik...2025-02-0636 min
Gesundheitspolitik im Fokus«Seltene Krankheiten. Wie steht es um die Gesundheitsversorgung der betroffenen Menschen?»mit Yvonne Feri, Präsidentin von ProRaris und Co-Präsidentin der Interessengemeinschaft Seltene Krankheiten, und FDP-Ständerat Matthias Michel, Co-Präsident der Interessengemeinschaft Seltene Krankheiten.
In der Schweiz sind heute rund 620'000 Menschen von einer, oft genetisch bedingten, seltenen Krankheit betroffen. Zahlenmässig wird eine Krankheit als selten eingestuft, wenn nicht mehr als 5 von 10'000 Menschen erkrankt sind. Oft stehen sie und ihre Angehörigen vor besonderen Herausforderungen, wie Schwierigkeiten bei der Diagnose, dem begrenzten Zugang zu spezialisierten Fachkräften und Medikamenten oder sozialen und psychologischen Belastungen. Mit der Einführung des Nationalen Konzepts Seltene Krankheiten im Jahr 2014 gab es Verbe...2024-11-0638 min
Gesundheitspolitik im Fokus«Strukturbereinigung in der Spitallandschaft – die Kantone im Driverseat»mit den Regierungsräten Lukas Engelberger und Jean-Pierre Gallati
Die Kantone spielen eine Hauptrolle, wenn es um die Spitäler in der Schweiz geht. Häufig sind sie Eigentümerin und haben bei der Planung und Finanzierung eine zentrale Verantwortung: Sie legen fest, welche Spitäler und Gesundheitsdienste in ihrer Region zur Verfügung stehen und sind massgeblich an der Finanzierung beteiligt. In den letzten Jahren sind immer mehr Spitäler in strukturelle und finanzielle Schieflage geraten. Die Branche steht unter massivem Transformationsdruck. Wie beurteilen die Gesundheitsdirektoren die Situation, mit welchen Rezepten bringen sie den nötigen Schwung in den Stru...2024-10-0836 min
Gesundheitspolitik im Fokus«Gesundheitswirtschaft unter Druck - wie reformfähig sind die Spitäler in der Schweiz?»mit Kristian Schneider, Spitaldirektor und Dr. Willy Oggier, Gesundheitsökonom
Die Konjunkturforschungsstelle der ETH Zürich erwartet für das Jahr 2024 Gesundheitsausgaben in Höhe von 95.3 Milliarden Franken, Tendenz weiterhin leicht steigend. Besonders unter Kostendruck stehen die Spitäler. Die Problemzonen sind seit geraumer Zeit bekannt. Die Notwendigkeit den Strukturwandel der Spitallandschaft anzupacken anerkannt. Trotzdem kommen Spitäler nicht schnell genug voran. Antworten auf die Frage, welche Massnahmen den nötigen Schwung bringen, um überholte Strukturen aufzubrechen und eine zeitgemässe Spitallandschaft zu gestalten geben die Gesundheitsökonomie und Best Practices.
Dieser Podcast wird von den Schweizer Niederlass...2024-09-1644 min
Gesundheitspolitik im Fokus«DigiSanté – was bringt die Digitalisierung dem Gesundheitswesen?»mit Anne Lévy, Direktorin Bundesamt für Gesundheit und FDP-Nationalrat Andri Silberschmidt
Die Digitalisierung im Gesundheitswesen braucht Schub. Der Handlungsbedarf ist gross. Mit dem vom Bund lancierten Programm DigiSanté geht es jetzt vorwärts. In den nächsten 10 Jahren sollen vier strategische Ziele erreicht werden: Digitalisieren, Orchestrieren, Standardisieren und Verankern will der Bund in Zusammenarbeit mit Leistungserbringern, Forschung, Industrie und Kantonen. Insgesamt sind 50 Vorhaben vorgesehen. Kostenpunkt für die Förderung der digitalen Transformation: 624 Millionen Franken. National- und Ständerat haben dem Verpflichtungskredit von knapp 400 Millionen Franken zugestimmt.
Dieser Podcast wird von den Schweizer Niederlassungen der Unterneh...2024-06-1736 min
Gesundheitspolitik im Fokus«Der Fachkräftemangel im Gesundheitswesen spitzt sich zu. Was ist zu tun?»mit FDP-Nationalrätin und Kinderchirurgin Dr. med. Bettina Balmer und GLP-Nationalrat und Pflegefachmann Patrick Hässig
Die Pandemie hat uns die Personallagen in den Gesundheitsberufen vor Augen geführt. Bis 2040 fehlen in der Schweiz schätzungsweise knapp 40’000 Fachleute in der Pflege und über 5’000 Ärztinnen und Ärzte. Haben wir es verpasst, den Gesundheitsberufen die nötige Aufmerksamkeit zu schenken? Was konkret sind die Ursachen und Auswirkungen, was die Lösungsansätze und Massnahmen gegen den Fachkräftemangel in den Gesundheitsberufen? Bettina Balmer und Patrick Hässig berichten, was politisch bereits aufgegleist ist und was die Leistungserbringer selber zu stemmen haben, um die Situation...2024-06-1036 min
Gesundheitspolitik im Fokus«Die 52. Legislatur: Was muss in der Gesundheitspolitik bis 2027 gelingen?»mit SP-Nationalrätin Barbara Gysi und SVP-Ständerat Hannes Germann
Wie schaffen wir den Durchbruch beim elektronischen Patientendossier (EPD)? Wie kann die Politik, der Bevölkerung den persönlichen Nutzen des #EPD aufzeigen? Die grösste Reform im Gesundheitswesen der letzten Jahre, die einheitliche Finanzierung von ambulanten und stationären Behandlungen kurz #EFAS, kommt dieses Jahr zur Abstimmung. Warum ist diese Reform wichtig für die Leistungserbringer und die Bevölkerung? Was sind die Vorteile von EFAS? Und wir sprechen auch darüber, ob die Kostendämpfungsversprechen tatsächlich realistisch sind.
Dieser Podcast wird von den Schweizer Niederlassu...2024-06-0334 min
Gesundheitspolitik im FokusTrailer «Gesundheitspolitik im Fokus»Der Gesundheitspodcast von Bristol Myers Squibb, Biogen Switzerland AG, MSD Switzerland und Novartis Pharma Schweiz | Moderation: Heike Scholten
Das Schweizer Gesundheitswesen zählt weltweit zu den besten, doch es steht auch vor grossen Herausforderungen. Gesellschaftliche, technologische und wirtschaftliche Veränderungen erfordern Anpassungen. Was darf Gesundheit kosten? Wie bleibt das Gesundheitswesen fit? Was ist uns die Gesundheit wert? Wir sprechen mit Expertinnen und Experten aus dem Gesundheitswesen, der Politik und aus der Wissenschaft über relevante gesundheitspolitische Themen, medizinische Fortschritte und darüber, wie wir die Balance zwischen hochstehender Versorgung und nachhaltiger Finanzierbarkeit schaffen. Gesundheitspolitik im Fokus – der Podcast für alle, denen e...2024-05-1301 min
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
PeerView Internal Medicine CME/CNE/CPE Video PodcastBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
PeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
PeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
PeerView Oncology & Hematology CME/CNE/CPE Video PodcastBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
PeerView Clinical Pharmacology CME/CNE/CPE VideoBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
PeerView Internal Medicine CME/CNE/CPE Audio PodcastBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastBenjamin Levy, MD - Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UFJ865. CME/MOC/AAPA/IPCE credit will be available until March 23, 2025.Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer In support of improving patient care...2024-03-1554 min
The Workplace#13 Lisa James-Holmes (Merck Sharp & Dohme, Australia & New Zealand)Welcome to the thirteenth episode of 'The Workplace' podcast, where we speak with Lisa James-Holmes, Associate Director, Strategy and Analysis JCAP and Global Workplace & Enterprise Services (GWES) for Merck Sharp & Dohme (MSD). In this exciting episode, we share the framework that shapes the WELL Building Standard and its differences to Greenstar Ratings before diving into Lisa's insights on;Her career journey to Workplace ExperienceThe International WELL Building Standard & Equity rating introducing this standard to leadership teams which ultimately led to; MSD's journey to achieving a Platinum WELL rating for their recent Sydney workplace refurbishment.Listen to t...2023-12-2128 min
ESC TV Today – Your Cardiovascular NewsAll you need to know about Lp(a) - Chronic total coronary occlusionsESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies All you need to know about Lp(a) Chronic total coronary occlusions Statistics Made Easy: The p-value Host: Perry Elliott Guests: Carlos Aguiar, Carlo di Mario, Lale Tokgozoglu Want to watch that episode? Go to: https://esc365.escardio.org/event/1141 Disclaimer This programme is intended for health care p...2023-12-0720 minESC TV Today – Your Cardiovascular NewsLAA occlusion - Chronic thromboembolic pulmonary hypertensionESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies LAA occlusion Chronic thromboembolic pulmonary hypertension Mythbusters: Do cholesterol lowering drugs provoke dementia? Host: Perry Elliott Guests: Carlos Aguiar, Stephan Rosenkranz, Jacqueline Saw Want to watch that episode? Go to: https://esc365.escardio.org/event/1140 Disclaimer This programme is intended f...2023-11-2320 minESC TV Today – Your Cardiovascular NewsCurrent indications for CRT - The polypill for CVD preventionESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Current indications for Cardiac Resynchronisation Therapy The polypill for cardiovascular disease prevention Snapshots Host: Perry Elliott Guests: Carlos Aguiar, Cecilia Linde, Valentin Fuster, Stephan Achenbach Want to watch that episode? Go to: https://esc365.escardio.org/event/1139 Disclaimer This programme is intended for health care professionals only and is to...2023-11-0919 min
ASCO EducationCancer Topics – ICC Program MalaysiaProviding high-quality cancer care to patients is the goal for any oncologist, yet there are many places across the globe that face multiple hurdles in achieving that goal. In this ASCO Education podcast we explore how one group is making a positive impact in the state of Surawak in Malaysia via the efforts of ASCO’s International Cancer Corp Program (ICC). Dr. Roselle de Guzman, past chair of the Asia Pacific Regional Council of ASCO, Dr Voon Pei Jaye medical oncologist and onsite director of the ICC Program at Sarawak and Dr. Evangelia D. Razis medical oncologist focused on neu...2023-08-1622 min
The Search for the Soulful Leader#27 - Leading Truly Inclusive Organisations w/ Robin Christopherson and Catherine WilliamsThis week, Phil King is joined by Catherine Williams and Robin Christopherson to discuss diversity and inclusion in organisations.Robin Christopherson of UK tech charity AbilityNet, is recognised as a leading expert on accessibility and digital inclusion. He is a regular speaker, raising awareness of the power and potential of technology to transform people's lives. His work was recognised with the award of an MBE in the 2017 Queen's new-year honour’s list for services to digital inclusion, as well as recently being awarded an honorary doctorate from the University of Suffolk department of Computer Science.Ca...2023-04-0450 minESC TV Today – Your Cardiovascular NewsAmong the topics: Primary prevention in the elderly – Acute and long-term treatment of pulmonary embolismESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Primary prevention in the elderly Acute and long-term treatment of pulmonary embolism Diagnostics Made Easy – “Getting things right” with the continuity equation for aortic stenosis Host: Susanna Price Guests: Jane Armitage and Stephan Rosenkranz Want to watch that episode? Go to: https://esc365.escardio.org/event/923 ...2023-03-2323 min
SeguroCastCalendário vacinal completo previne mais de 20 doençasSe por um lado a pandemia de Covid-19 impulsionou um enorme crescimento da vacinação, por outro também mostrou que o calendário de vacinação de adultos e crianças anda sendo negligenciado. Segundo dados da Merck Sharp & Dohme (MSD), as proteções mais procuradas pelos brasileiros são contra Covid-19, poliomielite, doenças pneumocócicas e Influenza - juntas somam mais de 80 milhões de doses, ou metade de todo o mercado de vacinação brasileiro. Até junho do ano passado, o país tinha registrado uma redução de 12,7% nas aplicações de vacinas gerais, quando comparado com o mesmo...2023-02-2310 min
Progress, Potential, and Possibilities Podcast / ShowMr. Temitayo Erogbogbo, Global Advocacy Director, MSD for Mothers (Merck Sharp & Dohme)Send us a textMr. Temitayo (Tayo) Erogbogbo, is Global Advocacy Director of MSD for Mothers (https://www.msdformothers.com/), at Merck Sharp & Dohme. Tayo has two decades of combined private sector and international development experience, 13 years of which was spent in the pharmaceutical industry in multiple roles across community relations, government affairs, marketing and sales. As the Global Advocacy Director of MSD for Mothers, Tayo is responsible for global and national strategic partnerships and programs to bring about policies and practice changes to improve maternal health care, and strengthen health systems, particularly where private sector approaches...2021-11-2453 min
Dr Robert Hess - Ready for the battle?Corona drug molnupiravir significantly reduces number of severe cases of disease and raises hopes, says manufacturerMerck Sharp and Dohme (MSD), the US pharmaceutical giant based in Kenilworth, New York, last week reported positive results from a Phase III trial of its new corona drug, molnupiravir. The manufacturer claim that it alleviates the course of the COVID-19 disease and halves the risk of hospitalization or death from a coronavirus infection. The potentially groundbreaking results promise a new way of treating COVID-19 and herald the first of hopefully many more antiviral drugs. Until now, COVID-19 has been treated with steroids such as dexamethasone and intravenous antibodies (MAB). Both are administered to patients who are already extremely ill...2021-10-1406 min
Mira quien HablaGabriela Bugarin con Carlos Mira en Mira quién Habla 04-OCT-2021Entrevista de Carlos Mira en Mira quién Habla a Gabriela Bugarin, medica infectologa en Merck, Sharp & Dohme, porque empresa farmacéutica Merck Sharp & Dohme (MSD) anunció que su píldora experimental COVID-19 redujo a la mitad las hospitalizaciones y muertes en personas recientemente infectadas por el coronavirus.2021-10-0517 min
Oncology Knowledge into Practice PodcastImmunotherapy series | Consensus best practice approaches to metastatic head and neck squamous cell carcinoma (HNSCC)Immune checkpoint inhibitors are a relatively new treatment option for patients with metastatic, unresectable head and neck squamous cell carcinoma (HNSCC), and so they have not yet been incorporated into clinical practice guidelines. For this reason, we interview Professor Frederic Peyrade, Head of Clinical Research and Professor of Oncology, Antoine Lacassagne Cancer Centre, France, to get expert advice on incorporating immune checkpoint inhibitors into current treatment protocols.
References
- Grégoire V, et al. Ann Oncol. 2009; 20 Suppl 4: 121-2
- Dimitrios Colevas, et al. J Natl Compr Canc Netw. 2018 May; 16(5): 479-490
- C...2020-10-2018 minOncology Knowledge into Practice PodcastImmunotherapy series | Selecting between first-line therapies in stage IV NSCLCSeveral immune checkpoint inhibitors have indications in non small-cell lung cancer (NSCLC), but it is not always easy to decide which patients to treat when, and with which regimen. In today’s episode, we’ve invited Professor Martin Reck from the Lung Clinic Grosshansdorf in Germany to answer some of our questions about best practice when considering immune checkpoint inhibitors for patients with NSCLC.
References:
Postmus PE, et al. Annals of Oncology. 2017; 28: iv1-iv21
Socinski MA et al. JCO. 2019; 37(15_suppl): 9012-9012
Pacheco JM. Translational Lung Cancer Research. 2019; 8(5): 723-727
Funazo T et...2020-10-0618 minOncology Knowledge into Practice PodcastImmunotherapy series | Assessing PD-L1 status: cytology vs histology in the real world settingHistological specimens are recommended to assess a patient’s PD-L1 status; however, it is not always easy or even feasible to secure a histological specimen in advanced cancers such as stage IV NSCLC. Cytological specimens are typically used in this setting to assess other molecular markers such as ALK or ROS1 – should they also be used to assess PD-L1 status?
This episode summarises the evidence for and against a cytological approach, before joining Professor Frederique Penault-Llorca for her opinion on whether cytology should be used to assess PD-L1 status in real-world practice.
References:
Gosney J, e...2020-09-2316 minOncology Knowledge into Practice PodcastImmunotherapy series | PD-L1 status: its role as a predictive biomarker and the relevance of “borderline” statusPD-L1 status has long been explored as a predictive biomarker for immune checkpoint inhibitors. However, the clinical evidence for its efficacy has been mixed, so how should PD-L1 status be used in clinical practice?
In the first episode in this series on immuno-oncology, Dr Vaibhav Patel from the Icahn School of Medicine at Mount Sinai, New York, answers questions about how PD-L1 status can or cannot influence treatment decisions in oncology.
References:
Kulangara K, et al. Arch Pathol Lab Med. 2019; 143(3): 330-337
Mok S, et al. Lancet. 2019; 393(10183): 1819-1830
Pacheco J. T...2020-09-0819 min
Logo Cedo PodcastEpisódio 6 - 22/07/2020Brasil ultrapassa 81 mil mortos e 2,1 milhões de infectados por Covid-19,
Com 1.346 novas mortes nas últimas 24 horas, o Brasil chegou a marca de 81.597 óbitos por covid-19. O país registrou também 44.887 casos confirmados de segunda para esta terça-feira, elevando para 2.166.532 o número de infectados.
Diretora espera que vacina contra a Covid-19 da BioNTech e da Pfizer seja aprovada entre outubro e novembro
A diretora da PFizer no Brasil, Márjori Dulcine, disse que espera obter, entre outubro e novembro, a aprovação para aplicação na população de uma das vacinas co...2020-07-2206 min
FarmaCast#024 – FarmaCast (Anticoncepcionais hormonais)
Hoje vamos conversar sobre um grupo de medicamentos que vão além da saúde, eles foram parte de uma grande revolução social, o feminismo. Atualmente eles já mudaram muito e se apresentam de diversas formas, venha conhecer um pouco mais sobre os anticoncepcionais hormonais.
Aguardamos seu contato. Visite nosso site, envie sugestões pelo post, pelo Instagram ou por e-mail. Teremos um grande prazer em te responder.
Esperamos que você goste e aguardamos seu feedback.
EXPEDIENTE
Conteúdo: Natália Bitu, Pablo Farias e Alyne Lemos
Ediçã...2020-05-271h 06
Stars of Learning PodcastEp 16: Master Class in Healthcare Marketing with Rohit Gulati from Karl StorzRohit Gulati - Head Strategy & Group Marketing at KARL STORZ GmbH & Co KG - India and Sub-Continent who is a Senior Strategic Commercial Leader with a progressive experience of 14 years in the Healthcare Industry. Rohit has worked in leading healthcare MNCs like DePuy Synthes (A Johnson & Johnson Company), MSD (Merck Sharp and Dohme), Bausch & Lomb and Becton Dickinson across Sales, Strategy, and Marketing functions. He is passionate about building high-value brands to fuel rapid revenue growth for both established and start-up companies. He possesses an entrepreneurial mindset and employs strong team leadership to create an outsized impact with limited...2019-12-051h 09